INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
Ado trastuzumab emtansine, a medication used to treat breast cancer that is HER2-positive, is discussed in great detail in this review article. Ado-trastuzumab emtansine, sometimes referred to as T-DM1, is an amalgamation of the cytotoxic DM1 medication and the anti-HER2 medicine trastuzumab. This medication works by delivering DM1 to cancer cells via attaching on the HER 2 receptor on cancer cells. Cell cycle interruption and death of cells (apoptosis) are the results of this. It has been demonstrated that ado-trastuzumab emtansine is successful in treating HER 2-positive, early-stage breast cancer. But it can also result in negative side effects like discomfort, exhaustion, and even heart damage. This medication is administered intravenously and is metabolised in the liver. It has a half-life of roughly 70 hours and is eliminated through the urine and stool.Ado trastuzumab emtansine may interact with other medications and may require dose adjustment. In general, this is a good way to treat HER2-positive breast cancer.
Keywords:
T-DM1, HER2-positive breast cancer, targeted treatment, combination therapy,clinical evidence,trastuzumab-emtansine.
Cite Article:
"DETAILED DRUG INFORMATION OF ADO TRASTUZUMAB EMTANSINE AND ITS THERAPEUTIC USES.", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 9, page no.b855-b861, September-2023, Available :http://www.ijnrd.org/papers/IJNRD2309198.pdf
Downloads:
000118760
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn